MedPath

KENT STATE UNIVERSITY

🇺🇸United States
Ownership
-
Established
1910-01-01
Employees
3.7K
Market Cap
-
Website
https://www.kent.edu

Clinical Trials

33

Active:1
Completed:20

Trial Phases

3 Phases

Phase 1:2
Phase 2:4
Not Applicable:26

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (32 trials with phase data)• Click on a phase to view related trials

Not Applicable
26 (81.3%)
Phase 2
4 (12.5%)
Phase 1
2 (6.3%)

Impact of a Mobile Phone and Educational Intervention

Not Applicable
Completed
Conditions
Pulmonary Disease, Chronic Obstructive
Asthma COPD
First Posted Date
2025-03-17
Last Posted Date
2025-03-17
Lead Sponsor
Kent State University
Target Recruit Count
29
Registration Number
NCT06878898
Locations
🇺🇸

Kent State University, Kent, Ohio, United States

Effects of Exercise Intensity on ADHD Symptoms

Not Applicable
Completed
Conditions
Attention Deficit Disorder with Hyperactivity
Attention Deficit Hyperactivity Disorder
ADHD
First Posted Date
2024-12-31
Last Posted Date
2024-12-31
Lead Sponsor
Kent State University
Target Recruit Count
28
Registration Number
NCT06753253
Locations
🇺🇸

Kent State University, Kent, Ohio, United States

Solarplast (R) Supplementation Effects Following High-intensity Resistance Exercise

Not Applicable
Recruiting
Conditions
Muscle Damage
First Posted Date
2024-05-29
Last Posted Date
2024-05-29
Lead Sponsor
Kent State University
Target Recruit Count
46
Registration Number
NCT06432868
Locations
🇺🇸

Kent State University - Exercise Science & Exercise Physiology, Kent, Ohio, United States

Transcranial Magnetic Stimulation in Smokers: an Examination of Mediating Neural Pathways.

Phase 2
Completed
Conditions
Smoking
First Posted Date
2022-12-15
Last Posted Date
2024-03-08
Lead Sponsor
Kent State University
Target Recruit Count
6
Registration Number
NCT05651334
Locations
🇺🇸

Cleveland Clinic Foundation, Cleveland, Ohio, United States

Examining Different Components of Online Acceptance and Commitment Therapy for People With Chiari Malformation

Not Applicable
Active, not recruiting
Conditions
Chiari Malformation
Chronic Pain
First Posted Date
2022-10-14
Last Posted Date
2023-06-15
Lead Sponsor
Kent State University
Target Recruit Count
113
Registration Number
NCT05581472
Locations
🇺🇸

Kent state University, Kent, Ohio, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

News

KNDY Neuron Research Leads to New Drugs for Infertility, Menopause Symptoms

Researchers have developed drugs targeting KNDY neurons to treat reproductive system malfunctions, including infertility and menstrual issues.

© Copyright 2025. All Rights Reserved by MedPath